Search

everythinglearnresearchcommunity

for

Search:↓

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

New small molecule drugs could help treat hair loss.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

PRP injections safely increase hair density and thickness in androgenetic alopecia.

The home-use IPL device effectively reduced hair and delayed its regrowth after six months of use, with users happy and no negative side effects.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

A blood pressure drug, diltiazem, may also help treat influenza.

Isotretinoin may cause hair loss, especially in women and young adults.

Apremilast shows promise for several skin conditions but needs more research.

PRP injections help hair regrowth safely but may need more research.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Azelaic acid is effective for treating rosacea, acne, and melasma.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Micro-needling effectively improves wrinkles, scars, and hair growth, but proper technique and safety are important.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Monitoring for adverse effects in clinical treatments is crucial.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.